SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback